
According to data from Benzinga Pro, during Q1, Aquestive Therapeutics's (NASDAQ:AQST) reported sales totaled $12.27 million. Despite a 54.33% increase in earnings, the company posted a loss of $13.22 million. In Q4, Aquestive Therapeutics brought in $11.08 million in sales but lost $28.95 million in earnings.